Ashura Buckley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ashura Buckley has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arun Azhagiri
Department of Neurology, Pathology 627, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21287, USA
1 shared publication - Audrey Thurm
Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health National Institutes of Health Bethesda MD USA
1 shared publication - Carlos A. Pardo
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
1 shared publication - David M. Neville
Pediatrics & Developmental Neuroscience Branch, National Institute of Mental Health, 10 Center Drive, Bldg 10/RM 1C250/MSC 1255, Bethesda, MD, 20892, USA
1 shared publication - Li-Ching Lee
Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, United States
1 shared publication - Susan E Swedo
Pediatrics & Developmental Neuroscience Branch, National Institute of Mental Health, 10 Center Drive, Bldg 10/RM 1C250/MSC 1255, Bethesda, MD, 20892, USA
1 shared publication
Latest Publications
- Open Access
- 8 April 2013
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 5 (1) , 9
A pilot open-label trial of minocycline in patients with autism and regressive features
Minocycline is a tetracycline derivative that readily crosses the blood brain barrier and appears to have beneficial effects on neuroinflammation, microglial activation and neuroprotection in a variety of neurological disorders. Both microglial activation and neuroinflammation have been reported to be associated with autism. The study was designed to evaluate the effects of minocycline treatment on markers of neuroinflammation and autism symptomatology in children with autism and a history of developmental regression.
- 8 April 2013
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 5 (1) , 9
Open AccessA pilot open-label trial of minocycline in patients with autism and regressive features
Minocycline is a tetracycline derivative that readily crosses the blood brain barrier and appears to have beneficial effects on neuroinflammation, microglial activation and neuroprotection in a variety of neurological disorders. Both microglial activation and neuroinflammation have been reported to be associated with autism. The study was designed to evaluate the effects of minocycline treatment on markers of neuroinflammation and autism symptomatology in children with autism and a history of developmental regression.